NM_001008661.3:c.454-1321A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001008661.3(KYAT3):c.454-1321A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.462 in 152,060 control chromosomes in the GnomAD database, including 16,373 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.46 ( 16373 hom., cov: 32)
Consequence
KYAT3
NM_001008661.3 intron
NM_001008661.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.48
Publications
14 publications found
Genes affected
KYAT3 (HGNC:33238): (kynurenine aminotransferase 3) This gene encodes an aminotransferase that transaminates kynurenine to form kynurenic acid, which is a metabolite of tryptophan. Multiple alternatively spliced transcript variants that encode different proteins have been described for this gene. This gene shares 5' exon structure with the RNA binding motif protein, X-linked-like 1 locus on chromosome 1, but the coding sequences are non-overlapping. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.494 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.462 AC: 70151AN: 151940Hom.: 16334 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
70151
AN:
151940
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.462 AC: 70237AN: 152060Hom.: 16373 Cov.: 32 AF XY: 0.456 AC XY: 33865AN XY: 74312 show subpopulations
GnomAD4 genome
AF:
AC:
70237
AN:
152060
Hom.:
Cov.:
32
AF XY:
AC XY:
33865
AN XY:
74312
show subpopulations
African (AFR)
AF:
AC:
17103
AN:
41474
American (AMR)
AF:
AC:
7698
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
1424
AN:
3468
East Asian (EAS)
AF:
AC:
2360
AN:
5166
South Asian (SAS)
AF:
AC:
1541
AN:
4824
European-Finnish (FIN)
AF:
AC:
4790
AN:
10548
Middle Eastern (MID)
AF:
AC:
117
AN:
294
European-Non Finnish (NFE)
AF:
AC:
33698
AN:
67984
Other (OTH)
AF:
AC:
986
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1958
3916
5874
7832
9790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
646
1292
1938
2584
3230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1538
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.